Unknown

Dataset Information

Does the Sequence of Anthracycline and Taxane Matter? The NeoSAMBA Trial.


ABSTRACT:

Background

Taxanes usually follow anthracyclines in breast cancer neo/adjuvant treatment, likely because of their later introduction into clinical practice. However, there is no biological rationale that justifies this current standard of care. We compared a taxane followed by an anthracycline-based regimen with the reverse sequence in the neoadjuvant setting.

Patients and methods

In a randomized, open-label, single-center phase II trial, women with inoperable, locally advanced, HER2-negative breast cancer were stratified by hormone receptor status and randomized to three cycles of docetaxel (T) followed by three cycles of fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus three cycles of FAC followed by three cycles of docetaxel. Surgery, radiotherapy, and adjuvan

SUBMITTER: Bines J 

PROVIDER: S-EPMC7485342 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature